Importantly, results from our BMT studies indicate that P2Y6 modulation of pro-inflammatory signaling in macrophages in vitro is highly relevant to the pathophysiology of atherosclerosis and helps explain the impact on disease development in vivo, where multiple inflammatory mediators likely coexist in the milieu of the atherosclerotic plaque. This evidence concerns the gene P2RY6 and atherosclerosis.